null

Zolbetuximab (Anti-CLDN18.2) Biosimilar Antibody

SKU:
HDBS0069
Product Type:
Biosimilar Antibody
Antibody Type:
Monoclonal Antibody
Protein:
CLDN18.2
Reactivity:
Human
Host Species:
Humanized
Isotype:
IgG1
€373
Frequently bought together:

Description

system_update_altDatasheet

Zolbetuximab (Anti-CLDN18.2) Biosimilar Antibody (HDBS0069)

The Anti-CLDN18.2 (Zolbetuximab Biosimilar) Antibody (HDbs0069) is a valuable tool for researchers studying CLDN18.2, a tight junction protein involved in maintaining epithelial barrier integrity. This monoclonal antibody, produced in mice, exhibits high specificity and sensitivity for detecting CLDN18.2 in various samples, making it suitable for use in immunohistochemistry and flow cytometry applications.CLDN18.2 is known to be overexpressed in certain cancers, particularly gastric cancer, where it serves as a potential therapeutic target.

By targeting CLDN18.2, researchers can investigate the role of this protein in cancer progression and explore novel treatment strategies. The Anti-CLDN18.2 Antibody (HDbs0069) provides researchers with a reliable tool for investigating the biological function of CLDN18.2 and its potential as a target for precision medicine approaches in cancer therapy.